CSA scores $20.5M in Series B

CSA Medical has secured $20.5 million in a Series B financing to support its currently marketed Spray Cryotherapy system. Intersouth Partners and First Analysis led the financing, with S.V. Life Sciences, Rose Park, Blue Heron Capital and other existing investors participating. The system is comprised of a device and specialty catheters that allow delivery of therapeutic doses of a cryogen to freeze and destroy unwanted tissue inside the body. CSA release

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.